中华耳科学杂志
中華耳科學雜誌
중화이과학잡지
CHINESE JOURNAL OF OTOLOGY
2014年
1期
37-40
,共4页
李琦%宋建敏%刘亚青%方如平%戴朴
李琦%宋建敏%劉亞青%方如平%戴樸
리기%송건민%류아청%방여평%대박
听力损失%儿童%基因诊断%突变
聽力損失%兒童%基因診斷%突變
은력손실%인동%기인진단%돌변
Hearing loss%Children%Genetic testing%Mutation
目的:进行新生儿听力筛查未通过者的基因诊断,探讨临床应用的价值。方法对110例42天OAE复筛双耳未通过的儿童进行GJB2基因,SLC26A4 c.919-2A>G、H723R,mtDNA1494和1555突变分析。结果发现和耳聋基因突变有关者23例,占检测者的20.9%(23/110),其中纯合或者复合杂合者6例,线粒体突变1例。发现GJB2致病纯合突变和复合杂合突变4例,杂合突变10例,发现出SLC26A4基因纯合突变和复合杂合突变2例,杂合突变6例,发现1555A>G突变1例。结论新生儿听力筛查未通过者的基因诊断在儿童感音神经性耳聋的早期诊断和干预方面有一定作用。
目的:進行新生兒聽力篩查未通過者的基因診斷,探討臨床應用的價值。方法對110例42天OAE複篩雙耳未通過的兒童進行GJB2基因,SLC26A4 c.919-2A>G、H723R,mtDNA1494和1555突變分析。結果髮現和耳聾基因突變有關者23例,佔檢測者的20.9%(23/110),其中純閤或者複閤雜閤者6例,線粒體突變1例。髮現GJB2緻病純閤突變和複閤雜閤突變4例,雜閤突變10例,髮現齣SLC26A4基因純閤突變和複閤雜閤突變2例,雜閤突變6例,髮現1555A>G突變1例。結論新生兒聽力篩查未通過者的基因診斷在兒童感音神經性耳聾的早期診斷和榦預方麵有一定作用。
목적:진행신생인은력사사미통과자적기인진단,탐토림상응용적개치。방법대110례42천OAE복사쌍이미통과적인동진행GJB2기인,SLC26A4 c.919-2A>G、H723R,mtDNA1494화1555돌변분석。결과발현화이롱기인돌변유관자23례,점검측자적20.9%(23/110),기중순합혹자복합잡합자6례,선립체돌변1례。발현GJB2치병순합돌변화복합잡합돌변4례,잡합돌변10례,발현출SLC26A4기인순합돌변화복합잡합돌변2례,잡합돌변6례,발현1555A>G돌변1례。결론신생인은력사사미통과자적기인진단재인동감음신경성이롱적조기진단화간예방면유일정작용。
Objective The current research aims is to investigate the clinical value of genetic testing in infants who do not pass the neonatal hearing screening and introduce together etiologic and audiological diagnosis of newborns. Methods We performed genetic testing for coding region of GJB2 gene,SLC26A4 c.919-2 and H723R mutation,mtDNA1494 and 1555 mutation in 110 newborns who do not pass the neonatal hearing screening in 42 days. Results 23 (20.9%) infants were detected to carry at least one mutation allele in GJB2, SLC26A4 or mitochondrial DNA. 6 (5.45%) infants were positive for hearing loss caused by GJB2 or SLC26A4 mutations (homozygote or compound heterozygote). 16(14.5%) infants are heterozy-gous of various genes. 1(0.91‰) infants had the pathological mitochondrial DNA mutation. Conclusions Detection of patho-genic mutations for hearing loss is bringing the possibility to identify children with non-syndromic deafness at an early stage. As a consequence, it will improve the current diagnosis and therapeutical option.